CVS Health shares climbed about 3% in Wednesday trading (April 29, 2026) as investors leaned into the name ahead of the company’s next earnings report, scheduled for May 6, 2026 before the market opens. Pre-earnings positioning and improving sentiment around the insurance segment helped lift the stock, after a period in which investors have been sensitive to medical-cost volatility and integration-related headlines. (marketbeat.com)

The bullish tilt centers on the view that Aetna’s medical-cost pressure is stabilizing and that Medicare Advantage fundamentals are becoming less of an overhang, supporting confidence in CVS’s ability to defend its 2026 outlook. Investors have also been revisiting Medicare Advantage rate dynamics as a forward-looking support for the group, which can feed into expectations for 2027 profitability even if it doesn’t immediately change near-term reported results. (washingtonpost.com)

The next catalyst is CVS’s quarterly report on May 6, when management commentary on Health Care Benefits margins, utilization trends, and any update to full-year guidance will likely determine whether today’s move holds. Traders will also be listening for incremental detail on performance improvement efforts across the broader portfolio, including the company’s primary-care assets, where prior impairment and rationalization actions have remained a key investor focus. (marketbeat.com)